Resumen de New Drug for Type 2 Diabetes

Diane S. Aschenbrenner

• * Albiglutide (Tanzeum), a glucagon-like peptide-1 agonist, has been approved by the FDA for the treatment of type 2 diabetes.

  * Patients who have a personal or family history of medullary thyroid carcinoma shouldn't be prescribed albiglutide.